Patents by Inventor Ethan B. Richman

Ethan B. Richman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240263228
    Abstract: Provided herein are devices, methods, and systems for next-generation volumetric in situ sequencing of nucleic acids in cells in intact tissue. In particular, methods are provided for improving robustness across sample types, including for thin and thick tissue volumes, and increasing the efficiency and specificity of target labeling for volumetric combinatorial in situ sequencing.
    Type: Application
    Filed: May 20, 2022
    Publication date: August 8, 2024
    Inventors: Karl A. Deisseroth, Ethan B. Richman
  • Publication number: 20240254553
    Abstract: Provided herein are devices, methods, and systems for multiple feature integration with next-generation three-dimensional in situ sequencing of nucleic acids in cells in intact tissue. Biological samples contain many distinct types of molecular, cellular, anatomical, and experimental features. The disclosed methods allow simultaneous interrogation of multiple distinct features of a biological sample, including RNA features, anatomical features, exogenous barcodes, or other arbitrary experimental features such as in vivo measurements, which can be combined into single experimental readouts with next-generation in situ sequencing.
    Type: Application
    Filed: May 20, 2022
    Publication date: August 1, 2024
    Inventors: Karl A. Deisseroth, Ethan B. Richman
  • Publication number: 20240254554
    Abstract: Sequencing chemistries and encodings for in situ gene sequencing are provided. Next-generation DNA sequencing and in situ sequencing techniques are dependent on robust, accurate, and efficient read out chemistries and encodings. The sequencing chemistries and encodings provided herein can be used with any commercial sequencing service in which sequencing readout is required. These chemistries and encodings may also be used for non-sequenced detection of target nucleic acids, multiplexed in situ labeling, and various applications in pathology and histology.
    Type: Application
    Filed: May 20, 2022
    Publication date: August 1, 2024
    Inventors: Karl A. Deisseroth, Ethan B. Richman
  • Publication number: 20240257912
    Abstract: Methods, systems, and devices, including computer programs encoded on a computer storage medium are provided for processing of next-generation in situ sequencing data for nucleic acids in cells in tissue. In particular, cloud-based scalable data processing software for volumetric in situ sequencing is provided.
    Type: Application
    Filed: May 20, 2022
    Publication date: August 1, 2024
    Inventors: Karl A. Deisseroth, Ethan B. Richman, Christopher M. Roat
  • Publication number: 20240248038
    Abstract: A sequencer for automated in situ sequencing of volumetric tissue samples is provided. In particular, an automated volumetric in situ sequencing device capable of operating on multiple samples in parallel is provided. Methods of fabrication and use of the sequencer are also provided.
    Type: Application
    Filed: May 20, 2022
    Publication date: July 25, 2024
    Inventors: Karl A. Deisseroth, Ethan B. Richman
  • Publication number: 20230346884
    Abstract: Methods of modulating dissociative and associative states in a subject are provided. In particular, neuromodulation of rhythmic neural activity in the posteromedial cortex can be used to induce or inhibit dissociative states in a subject.
    Type: Application
    Filed: August 9, 2021
    Publication date: November 2, 2023
    Inventors: Ethan B. Richman, Josef Parvizi, Jaimie M. Henderson, Paul Nuyujukian, Felicity Gore, Isaac V. Kauvar, Sam Vesuna, Karl A. Deisseroth
  • Publication number: 20230109070
    Abstract: Provided herein are devices, methods, and systems for in situ gene sequencing of a target nucleic acid in a cell in an intact tissue. Methods of screening a candidate agent to determine whether the candidate agent modulates gene expression of a nucleic acid in a cell in an intact tissue are also provided herein.
    Type: Application
    Filed: October 15, 2020
    Publication date: April 6, 2023
    Inventors: Ethan B. Richman, William E. Allen, Karl A. Deisseroth